Buckingham Research Downgrades Imperva (IMPV) to Neutral
Tweet
Share
E-mail
Get Alerts IMPV Hot Sheet
Price: $55.74 --0%
Rating Summary:
10 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
10 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Buckingham Research downgraded Imperva (NYSE: IMPV) from Buy to Neutral.
"Limited Upside as Takeout Increasingly Priced in," the analyst said.
For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.
Shares of Imperva closed at $53.18 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$231 at Bernstein SocGen
- Oxford Industries (OXM) PT Lowered to $40 at UBS Amid Top-line Weakness
- Seneca Foods (SENEA) PT Raised to $202 at Freedom Broker
Create E-mail Alert Related Categories
Analyst Comments, DowngradesRelated Entities
Buckingham ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
